GGrantIndex
Sort

39,280 grants matching leukemia

Accelerate cellular immunotherapy development for treatment of life-threatening childhood disorders

$1,395,617
Julie R Park · Seattle Children'S Hospital · U01 · FY2022 · TR

Tobacco Carcinogenesis and Chemoprevention

$1,395,357
Institute For Cancer Prevention · P01 · FY2004 · CA

Washington University/ Siteman Cancer Center Lead Academic Site

$1,394,352
Nancy L Bartlett · Washington University · U10 · FY2018 · CA

Cancer Risk and Environmental Exposures

$1,393,963
Mary H Ward · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA

COG NCTN Network Group Operations Center

$1,393,520
Peter C Adamson · Children'S Hosp Of Philadelphia · U10 · FY2017 · CA

Hematopoietic stem cell commitment

$1,393,353
Daniel G Tenen · Beth Israel Deaconess Medical Center · P01 · FY2012 · DK

SPORE University of Texas M. D. Anderson Cancer Center-Leukemia

$1,392,864
Marina Y Konopleva · University Of Tx Md Anderson Can Ctr · P50 · FY2018 · CA

Immunobiology and Immunotherapy of Pediatric Cancer

$1,392,377
Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Comparative Mechanisms of Cancer Chemoprevention

$1,392,370
Roderick H Dashwood · Texas A&M University Health Science Ctr · P01 · FY2014 · CA

Customized stem cells for clinical application in blood disorders

$1,391,696
George Q Daley · Boston Children'S Hospital · R24 · FY2015 · DK

Improving the Outcome of Patients with Chronic Myeloid Leukemia Through Medi

$1,390,873
Jorge E Cortes · University Of Tx Md Anderson Can Ctr · P01 · FY2010 · CA

Accelerate cellular immunotherapy development for treatment of life-threatening childhood disorders

$1,390,827
Julie R Park · Seattle Children'S Hospital · U01 · FY2021 · TR

Next Generation GPC2-CARs for Medulloblastoma

$1,390,720
Crystal Mackall · Stanford University · UG3 · FY2024 · CA

Next Generation GPC2-CARs for Medulloblastoma

$1,390,720
Crystal Mackall · Stanford University · UG3 · FY2025 · CA

Leukemia Signatures for Risk Classification & Targeting

$1,388,594
Cheryl L Willman · University Of New Mexico · U01 · FY2007 · CA

Leukemia Signatures for Risk Classification & Targeting

$1,388,417
Cheryl L Willman · University Of New Mexico · U01 · FY2006 · CA

Regulation And Function Of Retroelements

$1,388,000
Henry L. Levin · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2015 · HD

Accelerate cellular immunotherapy development for treatment of life-threatening childhood disorders

$1,386,496
Julie R Park · Seattle Children'S Hospital · U01 · FY2020 · TR

T-cell Transformation by Oncoviruses

$1,386,252
Genoveffa Franchini · Basic Sciences · Z01 · FY2007 · CA

OSU as Network Lead Academic Participating Site for the NCI NCTN

$1,384,556
Clara D Bloomfield · Ohio State University · U10 · FY2016 · CA

Genetic Approaches To Understanding Organ Development and Function

$1,384,483
Lothar Hennighausen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2012 · DK

OSU as Network Lead Academic Participating Site for the NCI NCTN

$1,383,057
Richard M Goldberg · Ohio State University · U10 · FY2015 · CA

Chromatin Insulator Function and Nuclear Organization

$1,382,530
Elissa Lei · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK

Molecular Basis for the Pathogenesis of Murine Retroviruses

$1,382,421
Sandra K Ruscetti · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Transplant Models

$1,380,789
Ronald Gress · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA